Data / Form D filings / Accu-Break Pharmaceuticals, Inc.
Accu-Break Pharmaceuticals, Inc.: Form D filings
Accu-Break Pharmaceuticals, Inc., a pharmaceuticals company in Hollywood, FL, filed 2 Form D notices with the SEC between 2013 and 2015. The latest, on June 2, 2015, reports $500,000 sold of a $1 million offering to 7 investors.
Find out what Accu-Break Pharmaceuticals, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 6100 HOLLYWOOD BOULEVARD, SUITE 307, Hollywood, FL, 33024
- Phone
- (954) 989-4150
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1398554
The full lists. Form D filings in Florida: 2,702 rows, $107.02, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jun 2, 2015 | New notice | $1,000,000 | $500,000 | $500,000 | 7 | May 29, 2015 | sec.gov |
| May 20, 2013 | New notice | $1,500,000 | $1,000,000 | $500,000 | 14 | Apr 24, 2013 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Elliot F. Hahn | Executive Officer, Director | |
| Robert I. Goldfarb | Executive Officer | |
| Nigel N. Norton | Director | |
| Mel E. Harris | Director | |
| Robert E. Baldini | Director | |
| David E. Lucking | Director | |
| Lloyd A. Moriber | Director | |
| John M. Siebert | Director |
Other pharmaceuticals companies in Florida that filed recently
- GOA Therapeutics Corp $300,000 · Nov 5, 2026
- DalCor Pharmaceuticals US, LLC $7 million · Aug 28, 2026
Every Form D from the week of Jun 1, 2015 · All recent filings in Florida · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Accu-Break Pharmaceuticals, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.